BR0012091A - Sal de difosfato de um derivado de 4 substituìdo-9-desoxo-9a-aza-9a-homoeritromicina e sua composição farmacêutica - Google Patents
Sal de difosfato de um derivado de 4 substituìdo-9-desoxo-9a-aza-9a-homoeritromicina e sua composição farmacêuticaInfo
- Publication number
- BR0012091A BR0012091A BR0012091-0A BR0012091A BR0012091A BR 0012091 A BR0012091 A BR 0012091A BR 0012091 A BR0012091 A BR 0012091A BR 0012091 A BR0012091 A BR 0012091A
- Authority
- BR
- Brazil
- Prior art keywords
- mammals
- methyl
- deoxo
- aza
- substituted
- Prior art date
Links
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical class OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 abstract 4
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 2
- 239000012458 free base Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010037075 Protozoal infections Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000884 anti-protozoa Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Patente de Invenção: "SAL DE DIFOSFATO DE UM DERIVADO DE 4"-SUBSTITUìDO-9-DESOXO-9A-AZA-9A-HOMOERITROMICINA E SUA COMPOSIçãO FARMACêUTICA". Esta invenção refere-se a um novo sal cristalino de difosfato de (2R,3S,4R,5R,8R, 10R, 11R, 12S, 13S, 14R)-13-[[2,6-didesóxi-3-C-metil-3-O-metil-4-C-[(propilamino)metil]-<2 44>-L-ribo-hexopiranosil]óxi]-2-etil-3,4-10-trihidroxi-3,5,8,10,12,14-he xametil-11-[[3,4,6-tridesoxi-3-(dimetilamino)-<225>-D-xilo-hexopirano sil]oxi]-1-oxa-6-azaciclopentadecan-15-ona que é útil como um agente antibacteriano e antiprotozoário em mamíferos. Esta invenção também refere-se a composições farmacêuticas contendo a base livre do sal de difosfato e a métodos para tratar infecções bacterianas e protozoárias em mamíferos pela administração da base livre do sal de difosfato a mamíferos com necessidade de tal tratamento. A base livre do sal de difosfato da presente invenção possui uma potente atividade contra várias infecções bacterianas e protozoárias quando dada por aplicação parenteral aos mamíferos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14168199P | 1999-06-30 | 1999-06-30 | |
| PCT/IB2000/000785 WO2001002414A1 (en) | 1999-06-30 | 2000-06-13 | Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0012091A true BR0012091A (pt) | 2002-04-02 |
Family
ID=22496734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0012091-0A BR0012091A (pt) | 1999-06-30 | 2000-06-13 | Sal de difosfato de um derivado de 4 substituìdo-9-desoxo-9a-aza-9a-homoeritromicina e sua composição farmacêutica |
Country Status (42)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465437B1 (en) * | 1999-06-30 | 2002-10-15 | Pfizer Inc. | Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition |
| US6791660B1 (en) * | 2002-02-12 | 2004-09-14 | Seiko Epson Corporation | Method for manufacturing electrooptical device and apparatus for manufacturing the same, electrooptical device and electronic appliances |
| US7468428B2 (en) | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
| US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
| WO2013013834A1 (en) | 2011-07-27 | 2013-01-31 | Farma Grs, D.O.O. | New crystalline forms of tulathromycin |
| CN106008622A (zh) * | 2016-08-02 | 2016-10-12 | 海门慧聚药业有限公司 | 泰拉霉素新晶型及其制备 |
| CN110885351A (zh) * | 2019-12-17 | 2020-03-17 | 海门慧聚药业有限公司 | 泰拉霉素磷酸盐的晶型及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI8110592A8 (en) * | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
| US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| SI9011409A (en) * | 1990-07-18 | 1995-10-31 | Pliva Pharm & Chem Works | O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
| JP2003512290A (ja) * | 1997-09-10 | 2003-04-02 | メルク エンド カムパニー インコーポレーテッド | 家畜抗菌剤としての８ａ−アザライド |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
| EP1189912B1 (en) * | 1999-05-18 | 2008-04-16 | Pfizer Products Inc. | Novel crystalline forms of a macrolide antibiotic |
| US6465437B1 (en) * | 1999-06-30 | 2002-10-15 | Pfizer Inc. | Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition |
-
2000
- 2000-05-18 US US09/574,160 patent/US6465437B1/en not_active Expired - Fee Related
- 2000-06-01 HN HN2000000090A patent/HN2000000090A/es unknown
- 2000-06-06 PA PA20008496901A patent/PA8496901A1/es unknown
- 2000-06-13 OA OA1200100329A patent/OA11965A/en unknown
- 2000-06-13 JP JP2001507850A patent/JP2003503506A/ja active Pending
- 2000-06-13 EE EEP200100699A patent/EE05068B1/xx not_active IP Right Cessation
- 2000-06-13 SK SK1892-2001A patent/SK286243B6/sk not_active IP Right Cessation
- 2000-06-13 ES ES00931491T patent/ES2233380T3/es not_active Expired - Lifetime
- 2000-06-13 CN CNA200710199182XA patent/CN101220067A/zh active Pending
- 2000-06-13 HR HR20010919A patent/HRP20010919B1/xx not_active IP Right Cessation
- 2000-06-13 EP EP00931491A patent/EP1189913B1/en not_active Expired - Lifetime
- 2000-06-13 CN CN00809635A patent/CN1358188A/zh active Pending
- 2000-06-13 AP APAP/P/2001/002370A patent/AP2001002370A0/en unknown
- 2000-06-13 EA EA200101178A patent/EA004235B1/ru not_active IP Right Cessation
- 2000-06-13 UA UA2001129148A patent/UA71013C2/uk unknown
- 2000-06-13 CZ CZ20014571A patent/CZ20014571A3/cs unknown
- 2000-06-13 AT AT00931491T patent/ATE286906T1/de not_active IP Right Cessation
- 2000-06-13 BR BR0012091-0A patent/BR0012091A/pt not_active IP Right Cessation
- 2000-06-13 AU AU49439/00A patent/AU772277B2/en not_active Ceased
- 2000-06-13 HU HU0201693A patent/HUP0201693A3/hu unknown
- 2000-06-13 KR KR10-2001-7016939A patent/KR100442508B1/ko not_active Expired - Fee Related
- 2000-06-13 PL PL352900A patent/PL201891B1/pl unknown
- 2000-06-13 IL IL14640888A patent/IL146408A0/xx unknown
- 2000-06-13 CA CA002376748A patent/CA2376748C/en not_active Expired - Fee Related
- 2000-06-13 MX MXPA02000058A patent/MXPA02000058A/es active IP Right Grant
- 2000-06-13 WO PCT/IB2000/000785 patent/WO2001002414A1/en not_active Ceased
- 2000-06-13 TR TR2001/03834T patent/TR200103834T2/xx unknown
- 2000-06-13 YU YU88701A patent/YU88701A/sh unknown
- 2000-06-13 DE DE60017399T patent/DE60017399T2/de not_active Expired - Fee Related
- 2000-06-13 PT PT00931491T patent/PT1189913E/pt unknown
- 2000-06-16 CO CO00045176A patent/CO5190679A1/es not_active Application Discontinuation
- 2000-06-26 UY UY26221A patent/UY26221A1/es not_active Application Discontinuation
- 2000-06-27 PE PE2000000645A patent/PE20010287A1/es not_active Application Discontinuation
- 2000-06-28 MY MYPI20002923 patent/MY133360A/en unknown
- 2000-06-28 GT GT200000105A patent/GT200000105A/es unknown
- 2000-06-28 MA MA26011A patent/MA26745A1/fr unknown
- 2000-06-28 TN TNTNSN00143A patent/TNSN00143A1/fr unknown
- 2000-06-28 AR ARP000103255A patent/AR035551A1/es not_active Application Discontinuation
- 2000-06-28 GT GT200000105AK patent/GT200000105AA/es unknown
- 2000-06-30 EC EC2000003555A patent/ECSP003555A/es unknown
-
2001
- 2001-11-13 IS IS6159A patent/IS6159A/is unknown
- 2001-11-20 BG BG106123A patent/BG65587B1/bg unknown
- 2001-12-19 NO NO20016221A patent/NO20016221D0/no not_active Application Discontinuation
- 2001-12-20 ZA ZA200110453A patent/ZA200110453B/xx unknown
-
2002
- 2002-08-12 US US10/218,154 patent/US6861412B2/en not_active Expired - Fee Related
-
2004
- 2004-05-06 US US10/840,529 patent/US7297682B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9714287A (pt) | Antibiótico cristalino designado solvato 6-o-metileritromicina forma 0, solvato de 6-o-metileritromicina forma 0, composição, processos para tratamento de infecções bacterianas em um mamìfero hospedeiro com necessidade de tal tratamento e para preparação de solvato de 6-o-metileritomicina a forma 0, 6-o-metileritromicina forma 0--etanolato, suspensão para administração oral, e, complexo de solvato de 6-o-metileritromicina a forma 0-carbÈmero. | |
| YU41500A (sh) | Novi makrolidi | |
| AU2002222296A1 (en) | Macrolide antibiotics | |
| UY25040A1 (es) | Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4' sustituidos | |
| UY25041A1 (es) | Derivados de macrolidos c-4" sustituidos | |
| CA2419801A1 (en) | Steroid derived antibiotics | |
| BR9710768A (pt) | Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i | |
| BR9916969A (pt) | Antibióticos cetólidos | |
| AP2001002142A0 (en) | 13-membered azalides and their use as antibiotic agents. | |
| NO20001439L (no) | 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet | |
| BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
| EP1114826A3 (en) | Novel antibacterial and prokinetic macrolides | |
| BRPI0414139A (pt) | métodos e composições para tratar infecções por herpes | |
| AP2001002370A0 (en) | Diphosphate salt of A4-substituted-9-deoxo-9A-aza-9a-homoerythromycin derivative and its pharmaceutical composition. | |
| BR9708929A (pt) | Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos | |
| GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
| WO2003089446A3 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
| BR0100228A (pt) | Macrolìdeos com 13 e 14 elementos antibacterianos e procinéticos e seus intermediários | |
| DK0649312T3 (da) | Anthracyclinkonjugater, deres fremstilling og deres anvendelse som antitumormidler | |
| WO2004000864A3 (en) | 11-c-substituted ketolides | |
| JPH07316059A (ja) | 細菌バイオフィルム形成阻害剤 | |
| NO995842L (no) | Multicykliske erytromycinderivater | |
| AR005136A1 (es) | Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamento | |
| CA2993425A1 (en) | Effective aminoglycoside antibiotic for multidrug-resistant bacteria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A E 11A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |